GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,767,000 | +12.8% | 40,595 | +12.8% | 0.01% | +27.3% |
| Q1 2022 | $1,567,000 | +1.8% | 35,978 | +3.1% | 0.01% | +10.0% |
| Q4 2021 | $1,540,000 | +19.8% | 34,913 | +3.8% | 0.01% | +11.1% |
| Q3 2021 | $1,285,000 | -0.2% | 33,639 | +4.1% | 0.01% | -10.0% |
| Q2 2021 | $1,287,000 | +22.2% | 32,320 | +9.6% | 0.01% | 0.0% |
| Q1 2021 | $1,053,000 | -8.0% | 29,502 | -5.2% | 0.01% | -9.1% |
| Q4 2020 | $1,145,000 | +1.7% | 31,123 | +4.0% | 0.01% | -15.4% |
| Q3 2020 | $1,126,000 | -11.3% | 29,915 | -3.9% | 0.01% | -13.3% |
| Q2 2020 | $1,270,000 | +4.6% | 31,144 | -2.8% | 0.02% | -11.8% |
| Q1 2020 | $1,214,000 | -16.4% | 32,032 | +3.6% | 0.02% | +6.2% |
| Q4 2019 | $1,453,000 | +6.8% | 30,917 | -9.1% | 0.02% | 0.0% |
| Q3 2019 | $1,361,000 | -2.3% | 34,020 | -2.3% | 0.02% | -5.9% |
| Q2 2019 | $1,393,000 | -18.5% | 34,807 | -14.9% | 0.02% | -19.0% |
| Q1 2019 | $1,709,000 | +74.0% | 40,900 | +59.1% | 0.02% | +50.0% |
| Q4 2018 | $982,000 | -12.2% | 25,710 | -7.6% | 0.01% | +7.7% |
| Q3 2018 | $1,118,000 | -22.9% | 27,825 | -22.7% | 0.01% | -27.8% |
| Q2 2018 | $1,450,000 | -99.9% | 35,981 | -0.1% | 0.02% | +5.9% |
| Q1 2018 | $1,407,244,000 | +38.1% | 36,019 | +25.3% | 0.02% | +41.7% |
| Q4 2017 | $1,019,356,000 | -26.3% | 28,739 | -15.6% | 0.01% | -33.3% |
| Q3 2017 | $1,383,119,000 | -11.8% | 34,067 | -6.3% | 0.02% | -14.3% |
| Q2 2017 | $1,567,724,000 | +9.3% | 36,357 | -2.4% | 0.02% | +5.0% |
| Q1 2017 | $1,434,924,000 | +98792.1% | 37,261 | -1.2% | 0.02% | -4.8% |
| Q4 2016 | $1,451,000 | -99.9% | 37,702 | -9.1% | 0.02% | -19.2% |
| Q3 2016 | $1,788,922,000 | +4.8% | 41,477 | +5.3% | 0.03% | 0.0% |
| Q2 2016 | $1,706,406,000 | -1.0% | 39,373 | -7.3% | 0.03% | -3.7% |
| Q1 2016 | $1,723,025,000 | -1.0% | 42,491 | -1.5% | 0.03% | -3.6% |
| Q4 2015 | $1,740,360,000 | +2.0% | 43,132 | -2.8% | 0.03% | -3.4% |
| Q3 2015 | $1,705,727,000 | -13.6% | 44,362 | -6.4% | 0.03% | -6.5% |
| Q2 2015 | $1,973,639,000 | -12.7% | 47,386 | -3.3% | 0.03% | -11.4% |
| Q1 2015 | $2,260,803,000 | +7.3% | 48,988 | -0.6% | 0.04% | +2.9% |
| Q4 2014 | $2,106,108,000 | -25.9% | 49,277 | -20.3% | 0.03% | -32.0% |
| Q3 2014 | $2,840,876,000 | -94.0% | 61,798 | -93.1% | 0.05% | -93.8% |
| Q2 2014 | $47,622,289,000 | +1.4% | 890,469 | +1.3% | 0.81% | -4.9% |
| Q1 2014 | $46,968,536,000 | +3.1% | 879,067 | +3.0% | 0.85% | 0.0% |
| Q4 2013 | $45,560,517,000 | +8.5% | 853,353 | +2.0% | 0.85% | -1.7% |
| Q3 2013 | $41,979,962,000 | +1.2% | 836,754 | +0.8% | 0.87% | -5.3% |
| Q2 2013 | $41,466,326,000 | – | 829,824 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |